These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19262959)

  • 1. Short review: Acetylcholinesterase-inhibitors in Alzheimer's disease have opposing effects on blood pressure and cerebral perfusion.
    Claassen JA; van Beek AH; Olde Rikkert MG
    J Nutr Health Aging; 2009 Mar; 13(3):231-3. PubMed ID: 19262959
    [No Abstract]   [Full Text] [Related]  

  • 2. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
    Van Beek AH; Claassen JA
    Behav Brain Res; 2011 Aug; 221(2):537-42. PubMed ID: 20060023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological correction of Alzheimer's disease (review of the literature)].
    Groppa SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nitrergic cerebrovascular regulation as affected by donepezil].
    Toda N
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):150-4. PubMed ID: 23470480
    [No Abstract]   [Full Text] [Related]  

  • 5. The short-term effect of acetylcholinesterase inhibitor on the regional cerebral blood flow of Alzheimer's disease.
    Cho H; Kwon JH; Seo HJ; Kim JS
    Arch Gerontol Geriatr; 2010; 50(2):222-6. PubMed ID: 19398134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease.
    Chaudhary S; Scouten A; Schwindt G; Janik R; Lee W; Sled JG; Black SE; Stefanovic B
    J Magn Reson Imaging; 2013 Jul; 38(1):26-35. PubMed ID: 23239554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibitors in Alzheimer's disease.
    McGleenon BM; Dynan KB; Passmore AP
    Br J Clin Pharmacol; 1999 Oct; 48(4):471-80. PubMed ID: 10583015
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral perfusional effects of 1-year rivastigmine treatment in Alzheimer disease: a case report.
    Ettorre E; Bersani FS; Colella F; Servello A; Minichino A; Megna V; Liberatore M; Biondi M; Marigliano V
    Riv Psichiatr; 2015; 50(4):188-91. PubMed ID: 26418600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
    Ebmeier KP; Hunter R; Curran SM; Dougal NJ; Murray CL; Wyper DJ; Patterson J; Hanson MT; Siegfried K; Goodwin GM
    Psychopharmacology (Berl); 1992; 108(1-2):103-9. PubMed ID: 1410128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
    Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
    Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
    Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
    Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
    Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic progress--review XVIII Alzheimer's disease.
    Kendall MJ; Chellingsworth MC; Main AN
    J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase inhibitors in late-stage Alzheimer's disease.
    Gauthier S
    Lancet Neurol; 2006 Jun; 5(6):468-9. PubMed ID: 16713915
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    Moyaert P; Beun S; Achten E; Clement P
    J Alzheimers Dis; 2023; 93(4):1211-1221. PubMed ID: 37182871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should cholinesterase inhibitors be used to treat Alzheimer's disease?
    Finucane TE; Gilstad JR
    Nat Clin Pract Neurol; 2006 Mar; 2(3):118-9. PubMed ID: 16932534
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic advances: donepezil for the treatment of Alzheimer's disease.
    Misson J; Kendall MJ
    J Clin Pharm Ther; 1997 Aug; 22(4):251-5. PubMed ID: 9548205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?
    Small DH
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):817-25. PubMed ID: 16262564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.